







Background/Objective: Systemic sclerosis is a severe autoimmune disease with unknown etiology and affects women three times more than men. It has been widely accepted that several environmental risk factors, especially for silica, are considered as potential triggers of SSc. A newly developed survey has been distributed among Pittsburgh SSc patients for better assessing the risk of occupational exposure. A Semi-quantitative method was utilized to evaluate the feasibility of the survey, and to further explore the association of occupational silica, chemical/solvent/others exposure and other pathways behind the unbalanced disease prevalence between gender.

Method: Raw data entry, categorization of parameters and calculation of semi-quantitative exposure scores were conducted using Excel. Analysis of descriptive and additional information was conducted case by case to evaluate the feasibility of the hybrid survey. Chi-square and fisher-exact tests of silica and chemical/solvents/others exposure were conducted to compare the different exposure patterns between male and female.
Results: There were 252 participants with complete checklist information and 11 participants had missing information. Although a total of 51 (34 females and 17 males) participants were self-identified as having occupational silica exposure, only 27 of them were classified as likely exposed to moderate or high occupational silica. In total, there were 6 participants who failed to identify themselves as occupational exposed, for an overall false negative rate of 3%. Significant difference were noted among silica exposure and non-exposure groups among males, and both male and females revealed remarkable differences in silica exposure intensity groups. Self-reported chemical/solvents and others exposures were significantly different by gender, with males   more likely to be influenced by multiple exposure substances. Further detailed information is required for further second-hand exposure and GIS analysis.

Conclusion: The hybrid questionnaire and semi-quantitative method revealed higher sensitivity of occupational silica exposure than the preliminary SSc cohort study, and significantly improved the response rate especially for chemical/solvent/others exposure. The accurate and uniform evaluating methods targeting manufacturing processes and products are essential in further research of SSc etiology. The awareness of the risk of personal occupation is of public health importance and can help reduce the possibility of being in contact with susceptible substances and should also be an emphasis in SSc prevention to further public health policy
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Systemic sclerosis (SSc) is a multisystem autoimmune disease whose pathogenesis is characterized by excessive fibrosis,, vascular injury and immune system activation. (). While the hallmark of the disease is fibrosis of the skin, but the more serious complications occur when the disease affects the internal organs including the gastrointestinal (GI) tract, lungs, heart and kidney (). Etiology of SSc remains unclear. Previous studies have suggested that various genetic factors may be involved including HLA alleles/non-HLA polymorphisms, and chromosomal abnormalities ().
1.2	Epidemiology and significance of SSc
SSc affects women 3-5 times more than men (), and some studies have shown remarkably high ratios up to 9:1 (). Although little is known about the genetic mechanisms underlying the gender difference in SSc prevalence, several theories have been established targeting fetal cell microchimerism  ADDIN EN.CITE (; ; ), CD 40L and X chromosome () and sex hormones (). Almost all age groups could develop SSc, ranging from childhood (4 to 5 years) to elderly (≥70 years). With peak onset between 30 and 50 years (; ). Ethnicity is also suggested to be a potential risk factor of SSc. African Americans tend to have more severe disease and earlier onset than Caucasians (; ). A retrospective cohort study in Michigan () reported lower mean age at diagnosis (44.5 years vs 51.5 years) and significant reduced age-adjusted survival rate among African American women with scleroderma. A twenty-year cohort study in Pennsylvania also found highest incidence of SSc among black women (21.2 per million) and slightly higher female-to-male incidence ratio during childhood years (15 to 44 years) (). 
1.2.1	Incidence and prevalence 
Incidence and prevalence of SSc varies considerably by geographic location, population studied, definition of disease and diagnostic methods (). The US has consistently reported the highest incidence and prevalence.  Among the areas out of the US, studies in Greece from 1981 to 2002 () and Northwestern Spain from 1988 to 2006 () revealed a prevalence range from 154 to 277 per million population and an incidence range from 11 cases to 23 cases per million population. A nationwide population study in Taiwan reported the prevalence of SSc to be 56.3 cases per million population and the incidence to be 10.9 cases per million population during 2002 to 2007 (). 
In the US studies, the prevalence of SSc varies from 100 to 300 cases per million population among general population (). A large survey of SSc cases conducted in the period 1989 to 1991 in the Detroit area revealed a prevalence of 242 cases per million adults (). A study in Quebec Canada based on the physician billing and hospitalization databases indicated that the SSc prevalence was examined to be as high as 443 cases in the year 2003 (). The overall incidence is around 18 to 20 per million populations and has tended to increase over the last 60 years, but the increasing trend was suggested due to the improvement in case detection and the variability in study methodology and designs (; ). 
1.2.2	Mortality, economic costs and manifestation
SSc has the highest case specific mortality among connective tissue diseases (). Crude mortality per year for SSc patients is 2.6% for females and 3.9% for males per year, and standardized mortality ratio of 4.6 for female and 3.6 for male in a UK retrospective inception cohort study (). Meta-analysis of cohort studies from multiple medical centers in the United States, Europe, and Japan reported standardized mortality ratios ranged between 1.5 and 7.2 comparing with expected deaths. (). 
Even though the survival rate of SSc has improved over the past three decades (), there is still no effective pharmacological therapy specifically targeting SSc other than disease-modifying and symptomatic treatments (), and the patient could only be treated with rehabilitation to prevent and reduce local disability (). The main economic burden has been due to hospitalizations and early retirement due to work disability (). SSc is also suggested to be one of the most severe chronic dermatologic diseases in terms of reduced quality of life (). A recent European study evaluated the economic burden and the health-related quality of life (HRQOL) among SSc patients concluded that SSc patients incur considerable average annual costs ranged from $ 4983 to $ 33,315 by country, and experience substantial deterioration in HRQOL (). Data from studies in Canada () and the US () corroborate the European studies. 
The manifestations of SSc including Raynaud’s Phenomenon, musculoskeletal symptoms (arthralgia, arthritis, flexion contractures, stiffness, proximal muscle weakness and tendon sheath involvement), pulmonary manifestations (interstitial lung disease, pulmonary hypertension, pleuritis and pleural effusion, and aspiration pneumonia), renal failure, gastrointestinal (gastroesophageal reflux, dysphagia and heartburn) and cardiac disease (pericarditis and myocardial fibrosis)  ADDIN EN.CITE (; ; ). In the US, interstitial lung disease (ILD) and pulmonary hypertension (PH) are the most life-threatening complications of SSc patients over the past 30 years (). This has also been supported internationally, where SSc related causes of death data from 1990 to 2009 in Spain were collected. With an overall mortality rate average of 66%, PH represented the leading cause of death throughout this period (). 
1.3	Risk factors
1.3.1	Genetic factors
Genetic risk factors seem to have modest influence on SSc. Since the year 2010, 45 genetic regions are currently suggested to be associated with SSc, and 15 of them have compelling genome-wide significance level based on multiple genome-wide association study (GWAS) and genotyping array of immune loci study results (). However, a large percentage of the SSc associated loci identified tend to be shared with one or more other autoimmune diseases including rheumatoid arthritis, primary biliary cirrhosis, and especially with systemic lupus erythematosus. (). In twin studies, low overall concordance of SSc in monozygotic twins (4.2%) compared to dizygotic twins (5.6%). (). SSc also demonstrated the lowest overall heritability score (0.008) among genetic heritability estimates of specific autoimmune diseases (). 
In general, autoimmune diseases affect more women than men (). The strongest gender differences were observed in Sjogren’s syndrome, SLE, autoimmune thyroid disease and scleroderma, followed by moderate gender bias detected in rheumatoid arthritis, multiple sclerosis, and myasthenia gravis (). Just like SSc, lupus erythematosus is also a female predominant (9:1) auto-immune disease with unknown etiology. The influence of sex hormones (estrogens, androgens, and differential sex hormone receptor-mediated events), X-chromosomes, feta-maternal chimeric and gut microbiota have been proved to be potential simulators of autoimmunity, and the environmental exposure (chemicals, silica, smoking and others) was considered to trigger the cells to become activated among genetically susceptible individuals (). To explain gender differences in SSc, modern genetic studies focused in possible risk factors including sex hormones, X-chromosome and fetal-maternal chimeric. However, to date, the effects of sex hormones such as estrogens in SSc have been scarcely explored. A few studies suggested abnormal sex hormones level play a role in SSc pathogenesis, but additional studies with larger sample sizes are still required for a decisive conclusion (; ). A recent study about X-chromosome related CD40L demethylation suggested significantly higher CD40L expression observed in female SSc patients than controls, but no difference was observed between male patients and controls (). Fetal-maternal chimeric is another popular theory regarding female patients and pregnancy, but there is still a lack of evidence to explain the disease existence in children, men and nulliparous women  ADDIN EN.CITE (; ; ). Although these theories have helped us better understand the potential contribution of SSc, they do not fully explain the pathogenesis of the significant gender differences. 
Since the current large-scale genetic studies are unable to fully explain the genetic etiology, disease pathogenesis and gender differences of SSc, the role for epigenetic effects of SSc is now beginning to be emphasized, a growing interest in environmental factors contributing to autoimmune disease emerged reflected by remarkably increasing articles since the year 1997 (). It is now widely believed that there is substantial genetic involvement and environmental triggering interaction in the contribution of SSc susceptibility. Studies have shown that SSc has been associated with exposures to substances in the environment, either through occupational or non-occupational exposures (; ). Prior studies also reported geographic clustering of SSc cases (; ) illustrating the probable spatial distribution of environmental influential factors. However, the high female to male ratio argues against heavy occupational exposure and may indicate gene environmental interaction with some unknown exposure.
1.3.2	Environmental factors and occupational exposure to silica
Multiple environmental agents including silica/silica dust, vinyl chloride, benzene, toluene, epoxy resins, heavy metal, mercury and drugs are considered to increase the risk of scleroderma occurrence (; ). One study has suggested that exposed patients seem to develop more severe forms of SSc, especially diffuse cutaneous SSc, severe microangiopathy, and ILD (). Among those environmental substances, silica and solvents exposure have the strongest known correlation with susceptibility to SSc as well as multiple systemic autoimmune diseases, and tend to have the highest possibility to be the environmental trigger of SSc (; ).  
Severity of occupational exposure is variable, with greater severity demonstrated for occupational exposure to silica dust among special populations. Raising great public concern, this has been especially true for men with construction-related occupations. Crystalline silica has been widely utilized in many industries such as sandblasting, rock drilling, cement manufacturing, clay and glass pottery, abrasives and many other construction activities, creating a remarkably high risk of exposure to silica dust among construction workers in the US (). While the majority of genetic and biological studies about SSc were conducted in female populations, most occupational exposure studies were focused in males due to the predominant higher male workers in the industrial and constructional areas. In the year 2009, at least 1.7 million US workers were estimated to be exposed to respirable crystalline silica (). The overall average personal occupational airborne crystalline silica dust exposure levels among US workers evaluated demonstrated an exceeding value compared with applicable American Conference of Governmental Industrial Hygienists threshold limit value (0.77 mg/m3 vs 0.05 mg/m3), and around 3.6% of the sampled workers were estimated as overexposed (). 
Multiple environmental risk factor studies were conducted focusing on the relationship between gender and occupational exposure to silica dust among SSc patients given the fact that majority of the construction workers exposed were males. A relatively higher risk of SSc was found in male (3.02) than female (1.03) with significant heterogeneity from a meta-analysis of occupational silica exposure studies published between 1967 and 2007 (). High risk ratio was also detected to be unbalanced for males (3.06) compared with females (2.10) by a mixed effect model in another recent meta-analysis of correlation between SSc and occupational silica exposure (). 
Similarly, in the preliminary University of Pittsburgh SSc cohort study (), information on incident cases presenting to the University of Pittsburgh Scleroderma Center recruited and diagnosed (n=746) between January 1, 2000 and December 31, 2014 was analyzed for exposure and disease phenotypes. In total, 135 (18%) SSc affected individuals self-reported occupational exposure data (categorized as none, solvent, silica/dust, other exposure, or ≥ 2 categories). Associations between exposure status and disease phenotypes (cutaneous subtype, serum autoantibody and pulmonary involvement) were evaluated. Although 78% patients recruited were female, more males (n=24) than females (n=14) reported an occupational exposure to silica No difference was found among exposed and unexposed groups in age, race, cutaneous subtype or serum autoantibodies. A significant association was detected between any occupational exposures and the phenotypic complications of SSc-ILD, while an increased frequency of SSc-ILD was found in correlation with either silica or solvent occupational exposure in the sub analysis. 
Tobacco smoking is a major confounder in SSc studies and has been linked to the development of multiple auto-immune diseases including SLE, RA and multiple sclerosis (MS) (; ). The primary effect of smoking not only interacts with genetic factors that increase the risk of the diseases, but also affects the severity and outcome of those auto-immune diseases (). However, smoking is not considered to be a risk factor of SSc disease development but proved to be associated with SSc-related disease severity (). Negative effects of cigarette smoking on vascular, gastrointestinal and respiratory outcomes in SSc patients have been determined (; ). 
1.4	methodological weakness of existing work 
Among most of the previous studies, more females were recruited in studies concordant with the unbalanced gender difference in disease prevalence. However, few females were exposed to occupational silica dust; this discordance revealed that the occupational silica exposure hypothesis, where more females are affected but the association between exposure and disease is seen more strongly in males remains unanswered. This restriction behind the heterogeneity in the meta-analysis might due to differences in study designs, population and geographic locations, ungeneralizable evaluation criteria and environmental exposure assessment methodology (). Further limiting this type of research is the lack of established animal models illustrating silica exposure pathway in humans to illustrate how much evidence is necessary or sufficient to define as a risk factor responsible for the development of the disease (). A majority of occupational exposure studies established the methodology of data collection varied by personal and telephone interviews  ADDIN EN.CITE (; ; ; ) and questionnaires (; ), classification of exposure based on job registries and occupational coding of job titles (; ). Most of the data collected were required to be validated and quantified by expert committee case by case  ADDIN EN.CITE (; ), which could be time-consuming and laborious. 
In the preliminary Pittsburgh SSc cohort study, more males than females were detected in the silica exposure group. Given remarkably more females were recruited in the study, the relationship between gender heterogeneity among SSc patients and occupational silica exposure remains unanswered. As the generally used methods were easily influenced by recall bias and exposure misclassification, an occupational description questionnaire method was developed utilizing and expanding upon a brief self-administered questionnaire in assessing occupational silica exposure in autoimmune disease (rheumatoid arthritis), as well as non-autoimmune entities (osteoarthritis and fibromyalgia) (CG Parks, 2006). This study was conducted to evaluate the feasibility of using this questionnaire in a population of SSc patients. The accuracy of the responses was evaluated and scored by an expert and demonstrated a high sensitivity and specificity in the assessment of occupational silica exposure. Additionally, the semi-quantitative method has been widely used in assessing multiple inhalation exposures  ADDIN EN.CITE (; ; ), as well as some of the occupational silica and solvent exposure in SSc patients  ADDIN EN.CITE (; ), which described a relatively more uniform evaluation criteria. The combination of those improved methods would provide us a more feasible assessment methodology in occupational silica exposure assessment.
1.5	PUBLIC HEALTH SIGNIFICANCE
Systemic sclerosis is a severe autoimmune disease with unknown etiology and affects women three times than men. SSc causes high mortality and morbidity worldwide, but there still no effective pharmacological therapy other than symptomatic treatments. The incidence and prevalence of SSc varied significantly by populations and studies, and the situation is more severe in the US than other regions. There are very few risk factors for this disease and low heritability which begs the question if there is a gene environmental interaction and or unknown risk factors which should be explored. Similar with SLE, sex hormones, X-chromosome and feta-maternal chimeric have been suggested to be strongly related with gender differences in SSc. Smoking is another potential risk factor associated with multiple auto-immune diseases that affects males more frequently than females. 
Occupational exposure to silica is widely considered as a trigger of SSc but the assessment of occupational silica exposure varied by study designs. Most of the studies utilized personal interview, telephone interview and non-uniformly designed questionnaires in data collection, and evaluation was conducted by selected epidemiologist committees or based on job registries and occupational coding of job titles, which might easily introduce exposure misclassification. In the previous Pittsburgh SSc cohort, occupational silica exposure was simply evaluated by self-reported occupational exposure categorizations including none, solvent, silica/dust, other exposure, or ≥ 2 categories, self-reported bias could be influential in accurately assessing occupational silica exposure status. The recently established occupational description questionnaire method represented a more feasible ability in silica exposure evaluation of multiple auto-immune diseases. We believed that the checklist and short description questionnaire in combination of the semi-quantitative method would be a more efficient and feasible alternative of previous assessment methods, and a better method to evaluate occupational silica exposure and its association with SSc. We will also detect gender differences and its potential association with other risk factors including solvents/chemical/others exposure, environmental exposure and second hand exposure to explore the probable causes result in the dramatic quantity variance between male and female. Including SSc, autoimmune diseases as a group has the highest prevalence in the US, and among the diseases with the highest mortality especially for young and middle-aged women (). Exploring the potential risk factors and causality of gender differences in SSc could also contribute to better understanding on other auto-immune diseases, improve people’s awareness of potential risk factors, and help in the development of further public health policy and strategies.
1.6	Objective
The main objective for this essay is to evaluate the feasibility of assessing silica exposure by self-administered questionnaire and expert review among SSc patients recruited from the University of Pittsburgh SSc Cohort. Also, we will further examine associations between other exposure substances (solvents, organic compounds, heavy metals, etc.) or other possible pathways (environmental and second hand exposures) among SSc patients and between genders.
2.0 	Methods
2.1	Study population and study design
In total of 263 self-administered questionnaires were collected from SSc patients recruited from University of Pittsburgh SSc Cohort study. The population of SSc cohort enrolled between 1995-2015 (N=1243) was 81% female, 89% Caucasian, average an age was 54 years and 58% never used tobacco. Surveys were either returned from patients by mail or obtained directly from clinics. This questionnaire () divides occupational silica exposure into 10 categories (Appendix A), and requests for extra information including occupation description, solvents and other occupational exposures, residential history, and cohabitant exposure information. 
This study was designed to evaluate the feasibility of assessing occupational silica exposure by self-administered questionnaire combining with semi-quantitative exposure assessment method. Raw survey data was input in the database constructed into categories including silica exposure types, age, duration, hours per week, occupation description, chemical/solvent/others exposure (positive or negative) and extra information for each participant. Occupation description was utilized for defining the accuracy of silica exposure type associated with each occupation belongs to. Combining silica exposure types and occupation description, semi-quantitative assessment parameters were defined by: 1) exposure probability (none exposure: 0, possible: 0.25, probable: 0.75 and definite: 1, which were defined by occupation description), 2) exposure frequency (<10%: 0.05, 10% - 50%: 0.3 and ≥50%: 0.75, which were defined by length of time worked daily), 3) exposure intensity (level 0-4, range from none exposure to highest level, defined by OSHA published silica occupational exposure reports) and 4) exposure duration, which is the time period between the date of occupation exposure to silica and the date of first SSc symptoms appeared, calculated by the age of starting the occupation, date of birth and the date of the first symptoms appeared. Only the onset of disease symptoms happened after the start listed of the occupation would be the exposure counted as eligible to contributed to the total duration. If the date of starting work was later than the date of symptoms began, the duration of this participant was defined as zero. The final exposure score was calculated by probability × intensity × frequency × duration, and cumulative scores were summed from each exposure scores for participants exposed to silica for more than 1 occupation. The final evaluation of semi-quantitative assessment was categorized as low exposure to very high exposure depending on the range of final exposure scores.
Data entry, categorization of parameters and calculation of exposure score were completed using Excel. Categorization of final score was conducted based on 25% and 75% quantiles of the final score range. Statistical analysis of silica exposure assessment included: 1) distribution and descriptive statistics of silica exposure score; 2) association between gender and silica exposed and non-exposed participants; 3) association between gender among silica exposure groups (medium, high and very high); 4) association between gender and solvent/chemical/others exposure (exposed or not exposed by self-report), 5) association between gender with exposure to both silica and solvent/chemical/others and 6) other possible pathways (environmental exposure and second hand contact) derived from descriptive information. All analyses were conducted using SAS version 9.4 (SAS Institute, Cary NC). Comparison between exposure groups and gender were conducted using Chi-square test or Fisher’s exact test as appropriate. P value less than or equal to 0.05 was considered statistically significant. 
3.0 	ResultS
3.1	Descriptive characteristics of study population
3.1.1	Self-administered survey and feasibility
Among the 263 surveys returned (overall response rate from mailing surveys: 34%, N=164), 228 were female and 30 are male (female: male is 7.6:1, 5 gender unknown). Smoking data was available for 254 participants, 55% (N=140) of them never used tobacco and 88% of them were female (N=224). A total of 62 participants were self-identified as having occupational silica exposure by checklist response (Figure 1), with 53.2% of the participants reported more than 2 exposure categories. Eleven individuals (~17.7%) with self-reported silica exposure were identified with missing data for either missing occupation start age or date of birth (n=7) or the intensity value of the occupation category was unable to be identified (n=3). One participant misidentified her husband’s occupation as her own on the checklist. This error was found based on the review of the descriptive information. 
Among those who self-identified with no occupational silica exposure, three women were possibly exposed to silica due to working together with their husband on the construction field (n=2) and helping with house building (n=1). Three participants self-identified as non-exposed but had a high possibility of occupational exposure to silica as railroad worker (n=1), firefighter (n=1) and concrete plant worker (n=1) based on the additional descriptive information they provided. For the participants with occupation exposure age later than symptom onset age, the exposure final score was defined as 0 (n=3). 
3.1.2	Occupational silica exposure 
By semi-quantitative evaluation, the final exposure score of the 51 participants with complete information (34 females and 17 males) was calculated (ranging from 0 to161.44), and four categories (low, median, high and very high) were identified based on the 25% and 75% quantiles of the final score data distribution. Relative low scores were identified among those who took a ceramics class as a hobby (scores range between 0.01 to 0.05), and high scores were derived from field construction workers conducting multiple tasks including sandblasting, grinding and cleaning manufacturing equipment (score range between 11.4 to 161.4). 
A total of 13 participants were categorized in the ‘low’ category (scores ranged from 0 to 0.32) which was rated as unexposed or low possibility of exposure to occupational silica, and the remaining categories (medium, high and very high) were evaluated as highly possible of exposure to silica in differing intensities. Detailed statistical analyses are summarized in Table 1. There was statistically significant difference in silica exposure status by gender, which among males the proportion of occupational silica exposure was significantly higher than females. There were no difference for females in the in the exposed vs non-exposed groups (N=21), but for males, there was a dramatic difference, demonstrating greater exposure (N=17) than non-exposure (N=3), p=0.01. Among participants identified as exposed to silica, among silica exposure groups (‘medium’, ‘high’ and ‘very high’) by gender, the p-value of 0.01 also illustrated a significant difference between gender and silica exposure intensity. Decreasing trend of exposure density was found among females by exposure groups (52.4%, 33.3% and 14.3%, respectively), while more males were categorized into ‘very high’ (52.9%) than ‘high’ (35.3%) or ‘medium’ (11.8%), revealed an opposite pattern comparing with females.
In sum, 252 participants with complete checklist information (263 surveys returned and 11 participants with missing checklist information), 10.7% (n=27) were classified as likely exposed to moderate or high occupational silica. In total of 6 participants are highly possible exposure to silica were unable to identify themselves as occupational exposure, revealed a false-negative rate of 2.99% among the total surveys. 
3.1.3	Other exposure evaluation
Association between self-reported chemical/solvents/others exposure (chemical solvents, organic compounds, heavy metal, radiation, etc.) by gender was evaluated by Chi-square tests (Table 1). Chemical exposure differed remarkably by gender, p=0.01. Many more females (N=109, 94.0%) reported chemical exposure than males (N=7, 2.8%), and based on the descriptive information, a large proportion of the females were exposed to general housekeeping solvents. The difference appeared to be more significant among participants who identified themselves as having both exposure types (self-reported silica exposure and chemical/solvents/others exposure). All 20 males reported to be exposed to both occupational silica and chemical/solvents/others, while 63% of females (n=26) reported with silica exposure without chemical/solvents/others exposure. As there is no control population we cannot assess whether the 45% ever smoking rate is higher that a suitable age matched control population.
Additionally, 17 women mentioned their husband or parents used to work in the occupations that were highly exposed to silica for a very long time (years to decades). Some mentioned they lived with their relatives who also had second hand exposure to silica for various intensity, however some did not describe whether they had direct contact or lived in the same place with their relatives. A total of 9 participants mentioned they lived in an area with possible silica exposure (close proximity to a steel mill, power plant, or grew up on the farm). 
4.0 	Discussion
For evaluation of the feasibility of a newly developed survey and further assessment of the association of occupational silica and chemical/solvent/others exposure between genders among SSc patients recruited from Pittsburgh SSc cohort study, 263 returned surveys were assessed by hybrid questionnaires and semi-quantitative method. Surveys were evaluated compared to the preliminary SSc cohort study, and personal occupational silica exposure possibility were evaluated by final scores. Among the 252 participants with complete checklist information (11 participants with missing checklist information), 51 were self-identified as occupational silica exposure, while only 27 of them were assessed as moderately or highly exposure to occupational silica. In total of 255 participants reported chemical/solvent/others exposure, and 46 of them reported with combined exposure to silica and chemical/solvent/others.
Gender difference of exposure assessment was significant, revealing a remarkably higher proportion of males correctly identifying themselves as having occupational silica exposure, although more female than males reported occupational silica exposure. Different patterns existed between males and female in silica exposure categories ‘medium’, ‘high’ and ‘very high’. Also, significantly more female than males identified themselves as being exposed to chemical/solvent/others, and all males with silica exposure on other checklist were also reported to be exposed to chemical/solvents/others compared with 63% of the females reporting with both exposures.
4.1.1	Evaluation of the hybrid questionnaire
In the preliminary Pittsburgh SSc cohort study, self-reported questionnaire about occupational exposure was categorized by none, solvent, silica/dust, other exposure, or ≥ 2 categories, and checklist was represented in occupational titles (farmer, sales, craftsmen, operatives, service workers, etc.). No additional descriptive, relative and geographic information provided for further identification and analysis. Other than recall bias, misclassification might be a concern, as plenty of participants might be unaware of the specific substance or exposure pathway related with silica or solvents during their working process, and the intensity and duration of exposure also varied by job tasks, revealed a low sensitivity and feasibility in exposure evaluation. Assessment methods used in other studies in related fields were either personal interview, telephone interview, non-uniformly designed questionnaires with committee review and semi-quantitative evaluation of job registries and occupational coding of job titles. Although personal and telephone interview by experts might obtain more detailed occupational information, the evaluation criteria could be varied by experts in the study, and the interview process could also be time-consuming, laborious and needs to be conducted under a strict condition. Non-uniform questionnaires and occupational coding of jobs could introduce the same problem in the study, and the nature of job registries and job coding could further influence the validity of the study due to misclassification.
In our study, the improved survey is composed of a checklist with detailed tasks, substance and operations (concrete sandblasting, rock bricklayer, house construction, etc.) instead of job titles, the occupation start time, frequency, length of occupation lasts and the additional descriptive information questions (about manufacturing methods and products). Two more additional questions were asked about their relatives’ exposure information and other related information the individual was concerned about but was not included within the checklist. Semi-quantitative method was used in evaluating silica exposure scores based on the checklists and related time information, which took working time duration and exposure intensity into account. A total of 24 out of 62 participants with positive self-reported exposure were defined with no silica exposure or non-occupational silica exposure including 3 participants with invalid occupational exposure duration (onset of disease prior to and therefore not due to occupation). With 21 of them female, there was a high proportion of false-positives represented among females, and could be strongly influential in further evaluation of gender differences in silica exposure status among SSc patients. Additionally, based on the descriptive information, 6 participants self-identified as non-exposed to silica were subsequently identified as possible or probable exposures, indicating that descriptive information is necessary in evaluating cases missed in the checklist and for those who were unable to correctly identify their exposure status. 
The strength of the hybrid method (checklist plus descriptive information) revealed an improved feasibility in preventing possible false positives and a higher sensitivity in self-identification. The combination of subsequent semi-quantitative evaluating method provided a more uniform criterion in assessing the distribution of occupational silica exposure intensity among a specific SSc population. Also, it provided further information in improving survey design in this field and yielded specific research questions regarding second-hand exposure and environmental exposure to silica and chemical/solvent/others. Lastly, this is the first study evaluating occupational silica exposure duration based on the onset time of the disease symptoms instead of occupation start time. The exposure duration after onset of symptom would not be counted as valid exposure duration, and for those disease symptoms started before occupation start were identified as non-exposed. Comparing with previous studies, it was more reasonable and reliable to assess the real exposure period for SSc patients in our study.
However, multiple weakness still existed in the questionnaire and assessment method which need further improvement. Recall bias is still problematic in our study. Occupation-related age and frequency could be unclear to older participants with multiple occupations or with early and mixed start age. Seven out of eleven missing data were derived from missing occupation-related time or date of birth, made it less feasible to calculate the occupation exposure proportion by this method. Misclassification could be represented in result of surveys we analyzed. For some of the checklist categories we might not ask the right questions especially for women, given 50% of women might incorrectly evaluate their exposure based on the checklist. Specific category needs to be added, such as firefighter, railroad constructor and dental lab staff, and clearly stated, such as the categories 11 and 12, silica-related substances are required to be specified (ever contacting soil or dust) to distinguish answers between ‘lived/grew up on a farm’ and ‘picking and sorting tobacco leaves’. Based on descriptive information, other categories could also be improved to emphasis the silica-original tasks or products to help the participants understand what we are searching for and avoid ambiguous answers, such as ‘have you been done or ever helped your husband or family in these tasks’. Besides, several women identified themselves as occupational silica exposure based on part-time ceramic work (or as hobby) with remarkably low amount of silica exposure. Although they were evaluated as no exposure or non-occupational exposure in this study, short-term or low intensity exposure could still be a possible trigger of SSc. 


4.1.2	Association of occupational silica exposure with SSc between gender
Exposure to silica has proved to increase the risk of scleroderma occurrence and associated with severe forms of SSc  ADDIN EN.CITE (; ; ). An overall relatively higher risk of SSc was found in males than female based on previous studies in regardless of study design and population (; ). Also in the Pittsburgh SSc cohort study, significantly more males (n=31, 23% of total participants) reported silica exposure than female (n=14, 2.4% of total participants) but almost equal number of male and female reported solvent exposure (23 vs 25). Remarkably higher proportion of female (90.2%) identified themselves as having no exposure to either silica dust, solvents or others than males (60.7%), and the total response rate was 6.3% for silica dust and 6.7% for solvents. We had higher proportion of checklist responses of exposure to both silica (23.6%) and chemical/solvent/others (97%) comparing with previous Pittsburgh SSc cohort study, and slightly higher numbers of females (n=42) than males (n=20) reported silica exposure by self-identification. After semi-quantitative evaluation, 21 females and 17 males were identified as possible occupational silica exposure, still revealed a higher silica exposure proportion (9.2% for female and 56.7% for males in total participants) than previous study result (). However, since our study was primary based on surveys returned by SSc patients enrolled in the SSc cohort, the results could potentially be biased by the proportion of patients who interested in the study. 
Although with higher absolute number of females exposed to silica, the proportion or relative risk for female is still lower than males, which is consistent with most of the previous studies. However, our study represented a lower relative difference (6.15) comparing with previous result (9.53) between males and females, also with a lower absolute difference (3 vs 17). Additionally, different patterns were demonstrated between males and females. Based on the distribution of silica exposure groups, females were more likely to identify themselves as silica exposure and tended to have lower silica exposure scores, while for males most of the self-identification was proved to be valid and accompanied with significantly high exposure scores. 
One possible explanation about the decreased gender exposure difference is due to the improvement of survey and evaluation methods which significantly increased the sensitivity of the survey and the validity of evaluation criteria. Another possible reason might due to the nature of male SSc patients generally having higher mortality rates and early mortality age  ADDIN EN.CITE (; ; ), resulting in less males that responded to our survey due to early mortality (the first recruitment period of the preliminary study in the SSc cohort was 2000-2014). The occupation differences between male and female might be responsible for the distinct exposure patterns. Since a higher proportion of males than females worked in the industrial and constructional area, the evaluation method in this study has eliminated large number of participants with low silica exposure scores especially for females, leading to unbalanced exposure distribution.
4.1.3	Other related risk factors evaluation
Chemical/solvent/others exposure evaluation was more complex to analyze than silica exposure due to specific effective compounds in those chemicals and solvents have not yet been identified, and the exposure intensity was more difficult to evaluate. In our study, only self-reported chemical/solvent/others exposure was considered, and a significant larger number of females reported with chemical/solvent/others exposure (n=225) than males (n=30). Most of exposure among females was derived from regular house cleaning at low frequency (7 to 8 hours per week), which is very prevalent among the general female population, potentially resulting in bias in chemical/solvent/others exposure evaluation. Nevertheless, all males reported exposure to both silica and chemical/solvent/others while 63% of the females exposed to silica reported experience of chemical/solvent/other exposure. The combined exposure could possibly be one of the risk factors results in the more severe morbidity rate among males.
Smoking is a major confounder in many auto-immune diseases very similar with SSc such as SLE, RA and MS. Although no evidence is found currently suggesting a significant association between smoking and risk of SSc, smoking has been shown proved to affect the severity of SSc outcomes. The smoking rate (45%) of the population in this study was over two times higher than the current smoking prevalence in general population ().  Since no control group was available in this study, evaluation of risk of smoking should be followed up in the future case control studies. Also, additional clinical manifestations data are required to for our further analyze the potential impact of smoking in this cohort.
The additional descriptive questions provided us information to consider in further research. Seventeen women had mentioned possible second-hand exposure in which their husbands or parents were intensely exposed to silica from their occupations. Nine participants mentioned they lived in the area with possible silica exposure (proximity to a steel mill, power plant, or grew up on the farm), and several participants had noticed extremely high Scleroderma or cancer rate around the places they lived. However, it was difficult to evaluate the validity and intensity accurately based on open-ended questions since important details were generally missing from those answers. Thus, in further research, the additional descriptive questions about second hand exposure could be improved by adding detailed categories (how long have you been living with relatives, dermal or inhale contact, exposure intensity, etc.) to obtain appropriate information for analysis, and environmental exposure would be evaluated by our further GIS analysis.
In conclusion, the hybrid questionnaire and semi-quantitative method revealed higher sensitivity of occupational silica exposure than the preliminary SSc cohort study, and significantly improved the response rate especially for chemical/solvent/others exposure. Based on the results it appears to be a feasible method and an alternative data collection tool in evaluating occupational silica exposure among SSc patients, and could be uniformly used in various studies despite of population and methodology. Further improvement in the questionnaire should be focused in accuracy of exposure categories and more organized descriptive information questions. This study helps us better understand of possible reasons about unbalanced SSc prevalence between male and female patients. Rather than working titles, more accurate and uniform evaluating methods targeting manufacturing process and products were proved to be an essential concern in further research of SSc etiology. Since no effective treatment available currently for SSc, the awareness of the risk of personal occupation and reduce the possibility of contacting susceptible substances is of great public health importance and should also be an emphasis SSc prevention in further public health policy and strategies development.
Appendix A: Self-administered Questionnaire (silica exposure)
Please think about your experience with each of these different jobs or tasks:	Circle one:	Please describe what you did and for any manufacturing, what products were made where you worked (write your answer below)	How old were you when you started this type of job or work?	How many years or months did you do this work?	How many hours per week?
Sandblasting (on any surface) or any abrasive blasting of stone or concrete; working in a foundry or metal mill	Yes     No		____years	____years____months	_____ hours
Working as a bricklayer or stone mason; other grinding, cutting, drilling, shaping, or polishing tile, cement, or rock	Yes     No		____years	____years____months	_____ hours
Any other abrasive grinding, drilling, cutting, shaping, or polishing or other materials (such as glass or metal)	Yes     No		____years	____years____months	_____ hours
Working in a rock quarry or any kind of mine; any other type of drilling or excavation of stone, gravel, sand, or dirt	Yes     No		____years	____years____months	_____ hours
Construction of homes, buildings, bridges, or roads; roofing; cleaning or other work on construction sites	Yes     No		____years	____years____months	_____ hours
Making cement, concrete, gypsum, plaster, rubber, plastics, or paints; or working in this kind of a factory	Yes     No		____years	____years____months	_____ hours
Making abrasive cleansers or powders, drugs, explosives, or cosmetics; or working in this kind of a factory	Yes     No		____years	____years____months	_____ hours
Making glass, tile, bricks, ceramics or pottery; or working in this kind of factory; sculpture or art with clay	Yes     No		____years	____years____months	_____ hours
Working on or near a tractor, planting seedlings, harvesting root crops (such as peanuts or potatoes)	Yes     No		____years	____years____months	_____ hours
Cleaning or sorting agricultural products (such as tobacco, peanuts, potatoes, or cucumbers)	Yes     No		____years	____years____months	_____ hours
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Table 1. Statistical tests of silica and chemical/solvent/others exposure by gender
	FemaleN (%)	MaleN (%)	P-value






Very High	3 (25)	9 (75)	
Self-reported Chemical/Solvent/ Others exposure			0.0095**
Yes	109 (93.97)	7 (2.75)	
No	116 (45.49)	23 (9.02)	
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